Skip to content

R&D at other companies

Solventum logo
SolventumSOLV
$189M-2.1%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$30M+18.6%
Stryker logo
StrykerSYK
$413M+2.0%
Medtronic logo
MedtronicMDT
$671M-1.9%
Novanta logo
NovantaNOVT
$23.25M+0.1%

Other financials

Income statement

See full
Revenue$59.9M+44.7%
Gross profit$42.3M+52.2%
Operating income-$6.5M+61.6%
Net income-$13.4M+35.4%
EPS (diluted)-$0.45+35.7%

Balance sheet

See full
Cash & equivalents$68.1M-1.6%
Total debt$252.7M+12.0%
Total equity$14.8M-61.7%
Total assets$351.0M+5.3%

Cash flow

See full
Operating cash flow-$4.3M+79.2%
CapEx$1.9M+146%
Free cash flow-$6.2M+71.3%

Valuation

See full
Market cap$2.56B+41.4%
Enterprise value$2.75B+38.7%
P/S11.2×+0.5×

Profitability

See full
Gross margin70.1%+3.7pp
Operating margin-12.4%-4.8pp
Net margin-19.1%-7.4pp
FCF margin-18.1%-6.6pp

Returns & leverage

See full
Return on equity-164%-17.8pp
Debt / equity17.1×+11.2×
Current ratio-0.4×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Establishment Labs's R&D?
Establishment Labs (ESTA) reported R&D of $5.24M in Q1 2026.
How has Establishment Labs's R&D changed year-over-year?
Establishment Labs's R&D increased by 3.7% year-over-year, from $5.06M to $5.24M.
What is the long-term trend for Establishment Labs's R&D?
Over 4 years (2021 to 2025), Establishment Labs's R&D has grown at a 2.5% compound annual growth rate (CAGR), from $18.32M to $20.25M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.